Detalles de la búsqueda
1.
Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.
Liver Int
; 44(6): 1343-1350, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38436529
2.
The correlation between immune-related adverse events and efficacy of immune checkpoint inhibitors.
Jpn J Clin Oncol
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38769817
3.
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study.
Int J Clin Oncol
; 29(2): 188-194, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991558
4.
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Oncologist
; 28(7): e526-e533, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37023703
5.
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study.
BMC Cancer
; 23(1): 177, 2023 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36809997
6.
A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma.
BMC Cancer
; 22(1): 517, 2022 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35525913
7.
Nal-IRI/5-FU/LV versus modified FOLFIRINOX and FOLFIRI as second-line chemotherapy for unresectable pancreatic cancer: A single center retrospective study.
Pancreatology
; 22(6): 789-796, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35705458
8.
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis.
Hepatol Res
; 52(3): 269-280, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34761470
9.
Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancer.
Cancer Sci
; 112(11): 4679-4691, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34382298
10.
Association between time to stent dysfunction and the anti-tumour effect of systemic chemotherapy following stent placement in patients with pancreaticobiliary cancers and malignant gastric outlet obstruction: a retrospective cohort study.
BMC Cancer
; 21(1): 576, 2021 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34011301
11.
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.
Hepatol Res
; 51(2): 201-215, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33270323
12.
Repeated Lusutrombopag Treatment for Thrombocytopenia in Patients with Chronic Liver Disease.
Digestion
; 102(4): 654-662, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32841939
13.
Three-Dimensional Imaging Using Contrast-Enhanced and Three-Dimensional Ultrasound Techniques in the Ablative Zone Treated with a Multipolar Radiofrequency Ablation System for Hepatocellular Carcinoma.
Oncology
; 90(5): 255-60, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26982013
14.
Randomized Controlled Trial Comparing the Efficacy of Impedance Control and Temperature Control of Radiofrequency Interstitial Thermal Ablation for Treating Small Hepatocellular Carcinoma.
Oncology
; 89(1): 47-52, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25790846
15.
HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy.
Liver Int
; 35(4): 1290-302, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25103089
16.
Therapeutic effects of short- and intermediate-term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis.
Hepatol Res
; 45(11): 1062-70, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25429910
17.
Utility of detection of telaprevir-resistant variants for prediction of efficacy of treatment of hepatitis C virus genotype 1 infection.
J Clin Microbiol
; 52(1): 193-200, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24197875
18.
Prevention of disease progression with anti-inflammatory therapy in patients with HCV-related cirrhosis: a Markov model.
Oncology
; 86(5-6): 295-302, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24924385
19.
Potential of a no-touch pincer ablation procedure for small hepatocellular carcinoma that uses a multipolar radiofrequency ablation system: An experimental animal study.
Hepatol Res
; 44(12): 1234-40, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24102816
20.
Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patients.
Hepatol Res
; 44(10): E163-71, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24397402